| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.06 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.07 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.07 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.098 | 0.07 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.07 |